News & Media

Avivagen is in the media as word about this scientifically-proven, natural product catches on around the world. Learn more about Avivagen’s recent news in the press releases below.

Press Releases

Avivagen Announces Update on Private Placement Process

January 20, 2020

Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S.

January 8, 2020

Avivagen Announces Closing of $1.25 Million Private Placement

January 3, 2020

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2019

December 20, 2019

Agreement with COFCO Biotechnology Sets Stage for Avivagen to Secure OxC-betaTM Livestock Approval in China

December 17, 2019

Avivagen Signs Memorandum of Understanding with Distribution Agent in Asia-Pacific

December 16, 2019

Learn more about the science behind Avivagen’s Pet Supplements

Avivagen is fueled by results—the results of our science and trials, and those who tell us they are living
their best lives now because of our patented products. Avivagen stands behind the science by providing
a pure form of the naturally-derived flavor agents that safely enhances feed consumption in
livestock.

Avivagen Inc. Head Office: 100 Sussex Drive, Ottawa, ON K1A 0R6 T. (613) 702-2908 E. avivagen@avivagen.com